Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
  • Portal Login
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
  • Portal Login

After 30 years, India began to make Penicillin G

  • March 3, 2024
  • Posted by: OptimizeIAS Team
  • Category: DPN Topics
No Comments

 

 

After 30 years, India began to make Penicillin G

Subject: Science and tech

Section: Health

Context:

The common antibiotic penicillin will be manufactured in the country for the first time in 30  years.

More on news:

  • Forty greenfield projects under the PLI schemes for manufacturing bulk drugs and medical devices were inaugurated on Saturday.
  • This included 27 greenfield bulk drug projects and 13 manufacturing plants for medical devices.
  • The bulk drug parks will produce active pharma ingredients for commonly used drugs.

About Penicillin:

  • Penicillin is a medication used to manage and treat a wide range of infections.
  • It is in the beta-lactam antibiotic class of drugs. 
  • This activity describes penicillin’s indications, action, and contraindications as a valuable agent in treating infection.

About Active Pharmaceutical  Ingredients:

  • These are the active ingredients contained in a medicine.
  • It is that part of the medicine that produces the intended therapeutic effects.
  • For example, in a painkiller, the active ingredient relieves pain.
  • In the OTC drug Crocin, the API is paracetamol.
  • Only a small amount of the API is required to produce the effect and so the medicine contains only the required amount of the API.
  • China is one of the largest producers of Key Starting Material (KSM) and APIs in the world

About Production Linked Incentive (PLI) Scheme:

  • The scheme expected to give a fillip to the domestic drug manufacturing industry is the PLI Scheme.
  • This scheme aims to promote the domestic manufacturing of, apart from APIs, drug intermediates and key starting materials (KSMs).
  • In this scheme, financial incentives will be provided to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years.
  • The scheme will be implemented through a Project Management Agency (PMA) to be nominated by the Department of Pharmaceuticals.

Drugs in news:

  • Atorvastatin: Reducing Cholesterol
  • Lopinavir: Treating HIV
  • Acyclovir: Treating infection such as shingles etc.
India began to make Penicillin G Science and tech

Recent Posts

  • Daily Prelims Notes 23 March 2025 March 23, 2025
  • Challenges in Uploading Voting Data March 23, 2025
  • Fertilizers Committee Warns Against Under-Funding of Nutrient Subsidy Schemes March 23, 2025
  • Tavasya: The Fourth Krivak-Class Stealth Frigate Launched March 23, 2025
  • Indo-French Naval Exercise Varuna 2024 March 23, 2025
  • No Mismatch Between Circulating Influenza Strains and Vaccine Strains March 23, 2025
  • South Cascade Glacier March 22, 2025
  • Made-in-India Web Browser March 22, 2025
  • Charting a route for IORA under India’s chairship March 22, 2025
  • Mar-a-Lago Accord and dollar devaluation March 22, 2025

About

If IAS is your destination, begin your journey with Optimize IAS.

Hi There, I am Santosh I have the unique distinction of clearing all 6 UPSC CSE Prelims with huge margins.

I mastered the art of clearing UPSC CSE Prelims and in the process devised an unbeatable strategy to ace Prelims which many students struggle to do.

Contact us

moc.saiezimitpo@tcatnoc

For More Details

Work with Us

Connect With Me

Course Portal
Search